Life Science Executive Partnering
Congress Sept 16-17, Forums Sept 15, 2025Thomas Michael Menino Convention & Exhibition Center, Boston, USAKey Sessions
Jessica Federer
Investing in Biotech Breakthroughs: A VC Outlook
Angelini Ventures
Mary Schaheen
Biopharma 2025: Innovation, Collaboration, and Transformation in a New Era of Healthcare
Prevail Partners LLC
Lei Meng
Series A Secured, What's Next? Scaling Your Biotech
Bain Capital Life Sciences
Scott DeWire
The Art of the Acquisition: Redefining Pharma’s Future Through M&A
Boehringer Ingelheim
Marian Nakada
Funding Biotech Innovation: The CVC Perspective
JJDC
Mike Patten
New Opportunities: How Asia’s Influence is Reshaping Biopharma in 2025
Harbour BioMed
Joe Heanue
Medtech’s Next Big Thing: Where the Big Players Are Placing Their Focus
Triple Ring Technologies
Wayne Jarvis
Mapping the Medtech M&A Landscape: Strategies for Companies in a Changing Market
Coloplast
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day 1 – Tuesday, 16 Sept 2025 - ET (Eastern Time, GMT-05:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Formats
Day 1 – Tuesday, 16 Sept 2025 - ET (Eastern Time, GMT-05:00)
search
Streams
Clear
Formats
Showing 1 of 1 Streams
Biotech Leaders Morning Keynote Plenary (Room 160 C, 160 B)
8:55am - 9:00am
LSX Welcome Address
9:00am - 9:50am
Biopharma 2025: Innovation, Collaboration, and Transformation in a New Era of Healthcare
- Mary Schaheen - President, Prevail Partners LLC
- Michael Cohen - Partner, Brown Rudnick
- Bibhash Mukhopadhyay - CEO; Chief Investment Adviser, Sapient Biotech Investments; Miletus Biotechnology
- Geeta Vemuri - Founder & Managing Partner, Agent Capital
9:50am - 10:30am
Impact of AI on the Future of the Pharmaceutical Industry
- Patricia Bradley - Global CCO, MindMaze
Showing 3 of 3 Streams
Biotech Leaders Capital Markets & Investment (Room 160 C, 160 B)
Biotech Leaders Partnerships & Deal Making (Room 161)
Market Opportunities & Commercialisation (Room 159)
11:00am - 11:40am
Investing in Biotech Breakthroughs: A VC Outlook
- Jessica Federer - Board Member, Angelini Ventures
- Jeffrey Quillen - Partner, Foley Hoag LLP
- Hal Paz - Operating Partner, Khosla Ventures
- Soyoung Park - General Partner, 1004 Venture Partners
- Sally Wang Liang - Managing Partner, Xpanse Venture
- Pierre Joffrin - Senior Associate, Syncona
11:00am - 11:50am
Partnerships That Pay Off: The Blueprint for Biopharma Success
- Steven Ladd - Vice President, Business Development & Acquisitions, BeOne Medicines USA
- Anu Connor - VP, Head of Oncology External Innovation, IPSEN
- Jonah Comstock - Editor in Chief, pharmaphorum
- Nikhil Mutyal - Head of Search and Evaluation - Respiratory & Immunology, AstraZeneca
11:50am - 12:40pm
Licensing Goldmines: Turning Intellectual Property into Biotech Success
- Carla Bauer - Director, Oncology S&E, BD&L, Merck
- Ryan O'Quinn - Partner, Finnegan
- Swarna Balasubramanian - Director BD S&E, AstraZeneca
- Alex Goddard - Director, McQuade Center for Strategic R&D, Otsuka Pharmaceuticals
11:00am - 11:40am
From Molecules to Millions: How to Build a Biotech Powerhouse
- Scott Saywell - EVP, Corporate Development, Coherus Oncology
- Jenny Holt - Chief Development Officer, Ray Therapeutics
- Christian Nodgaard - Manager, RSM
- Milenko Cicmil - CEO & Co-Founder, Tasca Therapeutics
- Rich Yang - CEO, Biolinq
12:00pm - 12:40pm
New Approach Methodologies (NAMs): Challenges and Opportunities for Biotech Innovators working to Reduce Animal Testing
- Julie Frearson - SVP Chief Scientific Officer, Charles River Laboratories
- Sara Hjuler - Director, Microphysiological Systems, Novo Nordisk
- Amir Bein - VP Biology, Quris ai
- Tina Morrison - VP, Scientific Strategy, EQTY Lab
- Stephen MacKinnon - VP, Applied Machine Learning, Recursion
Showing 3 of 3 Streams
Biotech Leaders Capital Markets & Investment (Room 160 C, 160 B)
Biotech Leaders Partnerships & Deal Making (Room 161)
Market Opportunities & Commercialisation (Room 159)
1:40pm - 2:30pm
Beyond the Pitch: Landing Early-Stage VC Funding
- Mahesh Narayanan - Managing Partner, Neuvation Ventures
- Salar Roshan - Operating Partner, 3E Bioventures Capital
- Giles Hamilton - Operating Partner, New Growth Advisors
- Sonia Gulati - Principal, Global BioAccess Fund
- Jarod Rutledge - Director of Biotechnology & Life Sciences, Starbloom Capital
- Laurent Audoly - CEO Co-founder, Prive Bio
2:30pm - 3:20pm
Series A Secured, What's Next? Scaling Your Biotech
- Lei Meng - Managing Director, Life Sciences, Bain Capital Life Sciences
- Ryan Dolan - Senior Managing Partner, Life Sciences, CFGI
- Evan Caplan - Principal, OrbiMed
- Jamil M. Beg - Partner, SV Health Investors
- Audrey Warner - Co-Founder & Managing Partner, 28 Capital
1:40pm - 2:30pm
Collaborating for Innovation: The Role of Research Partnerships in Biotech
- Urvashi Bhatnagar - Managing General Partner, The Good Science Fund
- Alison Fenney - Executive Director, Strategic Partnerships & Business Operations, Regeneron Genetics Center
- Alicia Zhou - CEO, Cancer Research Institute
- Peng Leong - CBO & Therapeutic Area Head, Brain Aging, BioAge
- Alfred Slanetz - Chairman, National Foundation for Cancer Research
2:30pm - 3:20pm
Sealing the Deal: Powering Autoimmune Breakthroughs Through Strategic Investment & Partnerships
- Laura Tadvalkar - Managing Director, RA Capital
- Saifur Rahman - Senior Director Business Development & Licensing, Sanofi
- Kyle LaHucik - Senior Reporter, Endpoints News
- John Mayfield - SVP, Business Development & Strategy, Flagship Pioneering
- Paul Oppold - VP, Investments & Head of Corporate Development, Roivant Sciences
- Teresa Whalen - CEO, CytoAgents
1:40pm - 2:20pm
New Opportunities: How Asia’s Influence is Reshaping Biopharma in 2025
- Mike Patten - Chief Strategy Officer, Harbour BioMed
- Rowan Walrath - American Chemical Society logo Associate Editor, Life Sciences Reporter, C&EN
- Armin Rump - Associate Director, Global Business Development, Otsuka Pharmaceutical
- Natalia Ulyanova - President & CEO, Nauka Consulting
- Osamu Nakanishi - President, Kissei America Inc.
2:20pm - 2:40pm
Navigating Tariff Impacts and Public Policy Shifts: Insights for the Life Sciences Industry
What is the current sentiment in Washington as it relates to the Healthcare and Life Science sector?
Understanding Tariff Impacts: How upcoming trade policies and tariffs are influencing supply chains, costs, and global competitiveness in the life sciences sector.
FDA: Given recent personnel changes in the FDA, updates on the administration and advice on how companies can best seek a collaborative relationship
Strategic Adaptation: How can companies proactively engage with policymakers to adjust business strategies to mitigate risks?
- Candi Wolff - EVP, Managing Director & Head of Global Government Affairs, Citi
- Kyle DiLella - East Coast Head of Life Sciences, Citi
Showing 1 of 1 Streams
Biotech Leaders Afternoon Keynote Plenary (Room 160 C, 160 B)
3:50pm - 4:40pm
Biotech's Next Chapter: Innovating Smarter in a Changing Financial Landscape
- Elizabeth Bailey - Co-Founder & Managing Partner, Foreground Capital
- Kristian Werling - Global Head, Health & Life Sciences Practice Group, McDermott Will & Schulte
- Luba Greenwood - CEO, Gallop Oncology
- Devin Rosenthal - Principal & Head of Due Diligence, NovaQuest Capital Management
- Bernard Cooney - Senior Partner, Flagship Pioneering
4:40pm - 5:30pm
The Art of the Acquisition: Redefining Pharma’s Future Through M&A
- Scott DeWire - Corporate SVP, Head of Global BD&L, Boehringer Ingelheim
- Nicole Daley - Partner, A&O Shearman
- Issei Tsukamoto - SVP, Global Head Business Development, Astellas Pharma
- Adam Keeney - EVP, Head of Coporate Development, Biogen
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Clear
Formats